| Trial ID: | L0129 |
| Source ID: | NCT00093977
|
| Associated Drug: |
Darbepoetin Alfa Sf
|
| Title: |
Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Disease|Chronic Kidney Disease
|
| Interventions: |
DRUG: darbepoetin alfa SF
|
| Outcome Measures: |
Primary: To determine whether darbepoetin alfa manufactured by a roler bottle technology (darbepoetin alfa RB) and darbepoetin alfa manufactured by a serum free process (darbepoetin alfa SF) have a comparable safety profile, Entire Study | Secondary: To characterize laboratory parameters in subjects with CKD, Entire Study
|
| Sponsor/Collaborators: |
Sponsor: Amgen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
1100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-10
|
| Completion Date: |
2007-01
|
| Results First Posted: |
|
| Last Update Posted: |
2013-05-24
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00093977
|
